The role of ascorbic acid in the prevention of atrial fibrillation after elective on-pump myocardial revascularization surgery: A single-center experience - a pilot study

Interactive Cardiovascular and Thoracic Surgery

Volumn 12, Issue 2, 2011, Pages 121-124

  Papoulidis, Pavlos ^a   Ananiadou, Olga ^a   Chalvatzoulis, Eleftherios ^a   Ampatzidou, Fotini ^a   Koutsogiannidis, Charilaos ^a   Karaiskos, Theodoros ^a   Madesis, Athanasios ^a   Drossos, George ^a  

^a G PAPANICOLAOU HOSPITAL   (Greece)

Author keywords

Ascorbic acid; Oxidative stress; PostCABG atrial fibrillation; Vitamin C

Indexed keywords

ASCORBIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO;

AGED; ARTICLE; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS GRAFT; DRUG EFFICACY; ELECTIVE SURGERY; FEMALE; HEART ATRIUM FIBRILLATION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERCHOLESTEROLEMIA; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINUS RHYTHM; VITAMIN SUPPLEMENTATION;

AGED; ANALYSIS OF VARIANCE; ASCORBIC ACID; ATRIAL FIBRILLATION; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LENGTH OF STAY; MALE; MYOCARDIAL REVASCULARIZATION; PILOT PROJECTS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURGICAL PROCEDURES, ELECTIVE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79551594615     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1510/icvts.2010.240473     Document Type: Article

References (15)

1. Chung MK. Cardiac surgery: postoperative arrhythmias. Crit Care Med 2000;28(Suppl 10):N136-N144.
2. Ommen SR, Odell JA, Stanton MS. Atrial arrhythmias after cardiothoracicsurgery. N Engl J Med 1997;336:1429-1434.
3. Almassi GH, Schowalter T, Nicolosi AC, Aggarwal A, Moritz TE, Henderson WG. Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg 1997;226:501-513.
4. Aranki SF, Shaw DP, Adams DH, Rizzo RJ, Couper GS, VanderVliet M, Collins JJ Jr, Cohn LH, Burstin HR. Predictors of atrial fibrillation aftercoronary artery surgery: current trends and impact on hospitalresources. Circulation 1996;94:390-397.
5. Allessie MA. Atrial fibrillation-induced electrical remodeling in humans: what is the next step? Cardiovasc Res 1999;44:10-12.
6. Khairy P, Nattel S. New insights into the mechanisms and managementof atrial fibrillation. CMAJ 2002;167:1012-1020.
7. Engelmann MD, Svendsen JH. Inflammation in the genesis and perpetuationof atrial fibrillation. Eur Heart J 2005;26:2083-2092.
8. Boos CJ, Anderson RA. Is atrial fibrillation an inflammatory disorder? Eur Heart J 2006;27:136-149.
9. Korantzopoulos P, Kolettis T, Siogas K, Goudevenos J. Atrial fibrillationand electrical remodeling: the potential role of inflammation andoxidative stress. Med Sci Monit 2003;9:RA225-RA229.
10. Carnes CA, Chung MK, Nakayama T, Nakayama H, Baliga RS, Piao S. Ascorbate attenuates atrial pacing-induced peroxynitrite formation andelectrical remodeling and decreases the incidence of postoperativeatrial fibrillation. Circ Res 2001;89:E32-E38.
11. Eslami M, Badkoubeth RS, Mousavi M, Avadi MR. Oral ascorbic acid incombination with beta-blockers is more effective than beta-blockersalone in the prevention of atrial fibrillation after coronary artery bypassgrafting. Tex Heart Inst J 2007;34:268-274.
12. Bruins P, te Velthuis H, Yazdanbakhsh AP, Jansen PG, van Hardevelt FW, de Beaumont EM, Wildevuur CR, Eijsman L, Trouwborst A, Hack CE. Activation of the complement system during and after cardiopulmonarybypass surgery: postsurgery activation involves C-reactive protein andis associated with postoperative arrhythmia. Circulation 1997;96:3542-3548.
13. De Vecchi E, Pala MG, Di Credico G, Agape V, Paolini G, Bonini PA, Grossi A, Paroni R. Relation between left ventricular function andoxidative stress in patients undergoing bypass surgery. Heart 1998;79:242-247.
14. Mihm MJ, Yu F, Carnes CA, Reiser PJ, McCarthy PM, Van Wagoner DR, Bauer JA. Impaired myofibrillar energetics and oxidative injury duringhuman atrial fibrillation. Circulation 2001;104:174-180.
15. Korantzopoulos P, Kolettis TM, Kountouris E, Dimitroula V, Karanikis P, Pappa E. Oral vitamin C administration reduces early recurrence ratesafter electrical cardioversion of persistent atrial fibrillation and attenuatesassociated inflammation. Int J Cardiol 2005;102:321-326.